This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
infectious peritonitis | 858 |
feline infectious | 858 |
feline coronavirus | 366 |
peritonitis virus | 334 |
type i | 209 |
feline coronaviruses | 201 |
type ii | 162 |
infected cells | 153 |
feline enteric | 134 |
enteric coronavirus | 131 |
virus infection | 129 |
fipv infection | 123 |
transmissible gastroenteritis | 117 |
coronavirus infection | 106 |
cell culture | 94 |
spike protein | 93 |
amino acid | 89 |
crfk cells | 87 |
gastroenteritis virus | 85 |
fipv strain | 78 |
cell line | 77 |
viral rna | 75 |
monoclonal antibodies | 71 |
dependent enhancement | 70 |
serotype ii | 69 |
hepatitis virus | 69 |
infected cats | 67 |
peripheral blood | 67 |
serotype i | 65 |
feline macrophages | 63 |
cell lines | 63 |
mouse hepatitis | 59 |
fip cats | 57 |
spf cats | 56 |
sequence analysis | 53 |
ii fipv | 53 |
i ku | 53 |
viral proteins | 53 |
immunodeficiency virus | 51 |
coronavirus infections | 51 |
i fipv | 51 |
canine coronavirus | 50 |
virus replication | 50 |
cats infected | 49 |
healthy cats | 49 |
tissue culture | 49 |
cord uid | 47 |
doc id | 47 |
coronavirus antibody | 47 |
respiratory syndrome | 46 |
alveolar macrophages | 44 |
mrna expression | 44 |
fipv replication | 43 |
viral replication | 42 |
present study | 42 |
genomic rna | 41 |
immune response | 40 |
enteric coronaviruses | 40 |
immune responses | 40 |
fipv type | 40 |
structural proteins | 39 |
gene expression | 39 |
clinical signs | 38 |
experimentally infected | 38 |
fipv black | 38 |
acute respiratory | 37 |
coronavirus isolates | 37 |
infected monocytes | 37 |
severe acute | 37 |
pfbm cells | 36 |
antigenic relationship | 36 |
cu cells | 35 |
circular tfo | 35 |
peplomer protein | 35 |
cancer cells | 35 |
culture supernatant | 35 |
virus type | 34 |
ii feline | 34 |
viral infection | 33 |
fecv strain | 33 |
survival factors | 32 |
antiviral activity | 32 |
nucleocapsid protein | 32 |
coronavirus spike | 32 |
naturally occurring | 32 |
murine coronavirus | 32 |
human cancer | 31 |
plaque assay | 30 |
antiviral treatment | 29 |
membrane fusion | 29 |
amino acids | 29 |
effusive fip | 29 |
mononuclear cells | 29 |
infected macrophages | 28 |
medium containing | 28 |
expressed viral | 28 |
porcine respiratory | 28 |
human immunodeficiency | 28 |
types i | 28 |
human coronavirus | 28 |
canine coronaviruses | 28 |
epithelial cells | 27 |
blood monocytes | 27 |
closely related | 27 |
fipv wsu | 27 |
respiratory coronavirus | 27 |
mg kg | 26 |
macrophage tropism | 26 |
feline alveolar | 26 |
immune system | 26 |
reverse genetics | 26 |
porcine transmissible | 25 |
virulent fipv | 25 |
cell cultures | 25 |
blood samples | 25 |
vaccinia virus | 25 |
cells infected | 25 |
expression levels | 25 |
cell differentiation | 25 |
veterinary medicine | 25 |
effusive form | 25 |
monocytes macrophages | 25 |
ii viruses | 25 |
cell surface | 24 |
plasma levels | 24 |
human coronaviruses | 24 |
mouse igg | 24 |
accessory genes | 24 |
cleavage site | 24 |
dengue virus | 24 |
fecv infection | 24 |
i feline | 24 |
cell fusion | 24 |
virus titers | 23 |
experimental infection | 23 |
significantly higher | 23 |
viral antigens | 23 |
two cats | 23 |
lymph nodes | 23 |
peritonitis viruses | 23 |
endemic feline | 23 |
important role | 23 |
virus strain | 23 |
reverse transcriptase | 23 |
viral infections | 22 |
felis catus | 22 |
fipv infected | 22 |
molecular biology | 22 |
recombinant vaccinia | 22 |
differentiation survival | 22 |
granulomatous lesions | 22 |
feline kidney | 22 |
calf serum | 22 |
pfu ml | 22 |
baff mrna | 22 |
cytokine mrna | 22 |
monoclonal antibody | 22 |
mapk pathway | 21 |
ii strains | 21 |
neutrophil survival | 21 |
post treatment | 21 |
fusion peptide | 21 |
fip virus | 21 |
peritoneal macrophages | 21 |
fipv strains | 21 |
family coronaviridae | 21 |
virus titer | 20 |
leukemia virus | 20 |
mg ml | 20 |
one cat | 20 |
time points | 20 |
specific pathogen | 20 |
i fcovs | 20 |
i fcov | 20 |
i viruses | 20 |
cell death | 20 |
field strain | 20 |
may also | 20 |
fipv antigen | 20 |
fecv type | 20 |
viral antigen | 20 |
antiviral effects | 20 |
plasma membrane | 20 |
molecular weight | 20 |
syndrome coronavirus | 19 |
naturally infected | 19 |
virus infections | 19 |
chain reaction | 19 |
diseased tissues | 19 |
acid sequences | 19 |
coronavirus type | 19 |
clinical disease | 19 |
room temperature | 19 |
occurring feline | 19 |
bronchitis virus | 19 |
host cell | 19 |
nucleotide sequence | 19 |
viruses arise | 19 |
antigenically related | 19 |
rna viruses | 19 |
infectious bronchitis | 19 |
western blot | 19 |
three times | 19 |
peritonitis feline | 19 |
open reading | 19 |
respiratory tract | 19 |
polymerase chain | 19 |
sars coronavirus | 19 |
faecal samples | 18 |
disease manifestations | 18 |
fcov infection | 18 |
blood mononuclear | 18 |
comparative sequence | 18 |
fluorescent antibody | 18 |
csf mrna | 18 |
rna polymerase | 18 |
cats experimentally | 18 |
cl pro | 18 |
domestic cats | 18 |
described previously | 18 |
fipv genome | 18 |
mrna levels | 18 |
feline immunodeficiency | 18 |
whole fetus | 18 |
culture medium | 18 |
acid sequence | 17 |
plasma cells | 17 |
i virus | 17 |
sequence identity | 17 |
accessory proteins | 17 |
bovine serum | 17 |
inflammatory cytokine | 17 |
catus whole | 17 |
alpha production | 17 |
time pcr | 17 |
rna sequence | 17 |
two biotypes | 17 |
tumor necrosis | 17 |
two different | 17 |
small intestine | 17 |
cellular immunity | 17 |
cytokine production | 17 |
post inoculation | 17 |
necrosis factor | 17 |
previously reported | 17 |
virulent virus | 16 |
feline monocytes | 16 |
highly conserved | 16 |
cell viability | 16 |
fcov strains | 16 |
coronavirus strains | 16 |
expression level | 16 |
infection studies | 16 |
porcine coronavirus | 16 |
mediated enhancement | 16 |
time point | 16 |
pcr products | 16 |
apoptosis induction | 16 |
risk factors | 16 |
passive immunization | 16 |
bone marrow | 16 |
gene region | 16 |
previous studies | 16 |
life technologies | 16 |
viral genome | 16 |
feline leukemia | 16 |
fcwf cells | 16 |
disease outcome | 16 |
fipv challenge | 16 |
bovine coronavirus | 16 |
phylogenetic analysis | 16 |
fetal calf | 16 |
protein gene | 16 |
ii strain | 15 |
main protease | 15 |
indirect fluorescent | 15 |
neutralizing activity | 15 |
strain fipv | 15 |
like protease | 15 |
breeding colony | 15 |
virus isolated | 15 |
developed fip | 15 |
ade activity | 15 |
weiss scott | 15 |
three cats | 15 |
feline peritoneal | 15 |
experimentally induced | 15 |
virus strains | 15 |
fatal disease | 15 |
target cells | 15 |
immune complexes | 15 |
porcine epidemic | 15 |
experimental studies | 15 |
tfo rnas | 15 |
sequence analyses | 14 |
antibody titers | 14 |
feline cells | 14 |
hours post | 14 |
th epitopes | 14 |
feline aminopeptidase | 14 |
american type | 14 |
spike proteins | 14 |
mediated lysis | 14 |
ii fcovs | 14 |
encephalomyelitis virus | 14 |
mapk activation | 14 |
immunized mice | 14 |
immunocompromised cats | 14 |
sequence data | 14 |
per cent | 14 |
intrinsic resistance | 14 |
virus production | 14 |
virus infectivity | 14 |
hr region | 14 |
epidemic diarrhea | 14 |
fipv isolates | 14 |
ii fcov | 14 |
different biotypes | 14 |
see ref | 14 |
kidney cells | 14 |
investigated whether | 14 |
positive cats | 14 |
fipv vaccine | 14 |
polypeptide specificity | 14 |
ascitic fluid | 14 |
virus neutralization | 14 |
hemorrhagic fever | 14 |
vivo virulence | 14 |
infected crfk | 14 |
related strains | 14 |
neutralizing antibody | 14 |
neutralizing antibodies | 14 |
goat anti | 14 |
well plates | 14 |
fc receptor | 14 |
live virus | 13 |
reading frames | 13 |
drug concentrations | 13 |
specific antibodies | 13 |
cell tropism | 13 |
organ samples | 13 |
oral route | 13 |
natural infections | 13 |
culture collection | 13 |
performed using | 13 |
previous study | 13 |
pg ml | 13 |
envelope protein | 13 |
determine whether | 13 |
atcc cells | 13 |
dengue hemorrhagic | 13 |
two related | 13 |
cat populations | 13 |
infected cell | 13 |
cell types | 13 |
type culture | 13 |
survival time | 13 |
membrane proteins | 13 |
infection correlates | 13 |
rna recombination | 13 |
molecular genetics | 13 |
also found | 13 |
buffered saline | 13 |
fecv strains | 13 |
fipv ku | 13 |
mesenteric lymph | 13 |
reverse transcription | 13 |
antigenic relationships | 13 |
progeny virus | 13 |
among cats | 13 |
reverse primer | 13 |
attempted immunization | 13 |
pathogenicity studies | 13 |
temperature sensitive | 13 |
cell monolayers | 13 |
untreated cells | 13 |
pathogen free | 13 |
triple helix | 12 |
vascular permeability | 12 |
pcr amplification | 12 |
fold change | 12 |
mm tris | 12 |
accessory gene | 12 |
double recombination | 12 |
crandell feline | 12 |
tfo rna | 12 |
splenocytes cultured | 12 |
fetal bovine | 12 |
transcription unit | 12 |
protein synthesis | 12 |
even though | 12 |
surface expression | 12 |
experimental conditions | 12 |
essential medium | 12 |
peritonitis coronavirus | 12 |
plasma drug | 12 |
membrane protein | 12 |
previously described | 12 |
experimental inoculation | 12 |
fipv orf | 12 |
antigenic sites | 12 |
hemagglutinating encephalomyelitis | 12 |
new strains | 12 |
clinical symptoms | 12 |
strand rna | 12 |
analyzed using | 12 |
nucleotide sequences | 12 |
antibody responses | 12 |
kindly provided | 12 |
containing fetal | 12 |
diarrhea virus | 12 |
gene mutations | 12 |
pbs containing | 12 |
endoplasmic reticulum | 12 |
recombinant viruses | 12 |
sublethal amounts | 12 |
kitasato university | 12 |
significantly increased | 12 |
culture fluid | 12 |
develop fip | 12 |
internal mutation | 12 |
infection kinetics | 12 |
cytopathic effect | 12 |
challenge exposure | 12 |
various feline | 12 |
positive cells | 12 |
pre post | 12 |
using feline | 12 |
protein genes | 12 |
regulated genes | 12 |
wild type | 12 |
recent studies | 12 |
cornell university | 12 |
avirulent live | 12 |
melting point | 12 |
systemic infection | 11 |
final concentration | 11 |
genomic organization | 11 |
genetic analysis | 11 |
coronavirus replication | 11 |
cells ml | 11 |
cells showed | 11 |
fip pathogenesis | 11 |
showed significant | 11 |
cat population | 11 |
western immunoblotting | 11 |
growth factor | 11 |
nervous system | 11 |
culture supernatants | 11 |
coronavirus genome | 11 |
body fluids | 11 |
results indicate | 11 |
protease inhibitor | 11 |
gene encoding | 11 |
feline interferon | 11 |
fipv cl | 11 |
viral reads | 11 |
lysis buffer | 11 |
polymerase gene | 11 |
activated protein | 11 |
experimental feline | 11 |
cell activation | 11 |
infectious diseases | 11 |
individual cats | 11 |
growth medium | 11 |
coronavirus strain | 11 |
pcr assay | 11 |
diseased cats | 11 |
dry form | 11 |
mutation theory | 11 |
fip resistance | 11 |
structural polypeptides | 11 |
active site | 11 |
envelope proteins | 11 |
protein kinase | 11 |
generation sequencing | 11 |
class i | 11 |
tnf receptor | 10 |
antigen expression | 10 |
mrna responses | 10 |
gene gapdh | 10 |
gastrointestinal tract | 10 |
highly virulent | 10 |
tcid ml | 10 |
inhibitory effects | 10 |
equal volume | 10 |
infected fcwf | 10 |
fipv may | 10 |
cats inoculated | 10 |
cell cycle | 10 |
growth curves | 10 |
antiviral effect | 10 |
relationships among | 10 |
per ml | 10 |
relative density | 10 |
structural protein | 10 |
viral growth | 10 |
total rna | 10 |
disease progression | 10 |
virus receptor | 10 |
fip disease | 10 |
pathologic changes | 10 |
central nervous | 10 |
mini kit | 10 |
rna isolation | 10 |
persistently infected | 10 |
virol doi | 10 |
fipv antibody | 10 |
viral spike | 10 |
infected kittens | 10 |
standard deviation | 10 |
target region | 10 |
three new | 10 |
following infection | 10 |
rna virus | 10 |
significantly inhibited | 10 |
blood lymphocytes | 10 |
protein cleavage | 10 |
hr protein | 10 |
programmed cell | 10 |
i ifn | 10 |
ml streptomycin | 10 |
eight cats | 10 |
strain wsu | 10 |
quantitatively analyzed | 10 |
cytokine responses | 10 |
incubation period | 10 |
mm edta | 10 |
primary feline | 10 |
pcr product | 10 |
field strains | 10 |
proteolytic cleavage | 10 |
respiratory disease | 10 |
uc davis | 10 |
antibody response | 10 |
two serotypes | 10 |
rsa i | 10 |
diseased omentum | 10 |
cell type | 10 |
determined using | 10 |
igg mabs | 10 |
resistant viruses | 10 |
protein levels | 10 |
cats suffering | 10 |
significant difference | 10 |
fipv receptor | 10 |
arch virol | 10 |
using avirulent | 10 |
cat environments | 10 |
minimum essential | 10 |
forward primer | 10 |
fipv df | 10 |
orf abc | 10 |
host cells | 10 |
housekeeping gene | 10 |
plasma samples | 10 |
receptor binding | 10 |
viral loads | 10 |
syncytium formation | 10 |
ml penicillin | 10 |
mouse anti | 10 |
reaction mixture | 9 |
specific primers | 9 |
bf sha | 9 |
rna extraction | 9 |
pathogenic differences | 9 |
small number | 9 |
dna polymerase | 9 |
rabbit anti | 9 |
four different | 9 |
fusion protein | 9 |
post infection | 9 |
utrecht university | 9 |
causative agent | 9 |
fipv infectivity | 9 |
gene sequences | 9 |
pyridinyl imidazole | 9 |
whole blood | 9 |
reading frame | 9 |
fipv exposure | 9 |
rna genome | 9 |
host responses | 9 |
strain fcov | 9 |
peritonitis among | 9 |
inoculated cells | 9 |
fipv inoculation | 9 |
inflammatory cytokines | 9 |
linked immunosorbent | 9 |
like particles | 9 |
fip development | 9 |
intact orf | 9 |
related cats | 9 |
mutant virus | 9 |
fipv ucd | 9 |
infected samples | 9 |
macrophages infected | 9 |
natural host | 9 |
genetic differences | 9 |
rna sequencing | 9 |
inhibitory effect | 9 |
copy number | 9 |
washed three | 9 |
viral particles | 9 |
expressed genes | 9 |
induced feline | 9 |
primary structure | 9 |
fip diagnosed | 9 |
results suggest | 9 |
signal sequence | 9 |
calculated using | 9 |
energy transfer | 9 |
signaling pathways | 9 |
animal coronaviruses | 9 |
clpro inhibitors | 9 |
applied biosystems | 9 |
diagnosed cats | 9 |
spleen cells | 9 |
treatment groups | 9 |
like agent | 9 |
th tc | 9 |
spike glycoprotein | 9 |
copy numbers | 9 |
blood vessels | 9 |
targeting non | 9 |
body temperature | 9 |
body cavities | 9 |
drugs strongly | 9 |
ccv strain | 9 |
virus particles | 9 |
reverse genetic | 9 |
indirect immunofluorescence | 9 |
natural history | 9 |
infection enhancement | 9 |
immunosorbent assay | 9 |
four related | 9 |
subsequent challenge | 9 |
domestic cat | 9 |
st cells | 9 |
premature stop | 9 |
birman cats | 9 |
differentially expressed | 9 |
infected cat | 9 |
cells may | 9 |
vascular endothelial | 9 |
two distinct | 9 |
vaccinated cats | 9 |
shelter cats | 9 |
coronavirus rna | 9 |
immunologic aspects | 9 |
immunologic phenomena | 9 |
feline blood | 9 |
cell entry | 9 |
fipv infections | 9 |
peplomer gene | 9 |
live fipv | 9 |
lactogenic immunity | 9 |
antiviral drugs | 9 |
adcml assay | 9 |
type immune | 9 |
influenza virus | 9 |
oral infection | 9 |
upper respiratory | 9 |
cell lysis | 9 |
virus neutralizing | 9 |
genome organization | 9 |
fusion process | 9 |
two viruses | 9 |
laboratory cats | 9 |
genetic drift | 9 |
either sb | 9 |
infected animals | 8 |
polyacrylamide gel | 8 |
recurrent feline | 8 |
increased levels | 8 |
transcriptome analysis | 8 |
crystal violet | 8 |
simplex virus | 8 |
virus isolation | 8 |
substrate solution | 8 |
ex vivo | 8 |
antigenic differences | 8 |
peritonitis pathogenicity | 8 |
human monocyte | 8 |
strain feline | 8 |
stop codon | 8 |
intestinal tract | 8 |
murine hepatitis | 8 |
circular tfos | 8 |
infectious disease | 8 |
kg dose | 8 |
cell lysates | 8 |
coronavirus mutants | 8 |
mice infected | 8 |
monocyte macrophage | 8 |
induced fip | 8 |
gene regions | 8 |
also showed | 8 |
cats used | 8 |
adopted shelter | 8 |
immune complex | 8 |
peptides derived | 8 |
positive results | 8 |
cellular receptor | 8 |
enteric infections | 8 |
wet form | 8 |
leader rna | 8 |
furin cleavage | 8 |
blood cells | 8 |
like proteases | 8 |
rna synthesis | 8 |
veterinary medical | 8 |
natural feline | 8 |
laboratory strain | 8 |
cdna synthesis | 8 |
enteric infection | 8 |
fip cases | 8 |
gene ontology | 8 |
evasion strategy | 8 |
density value | 8 |
time rt | 8 |
different time | 8 |
virus propagated | 8 |
target regions | 8 |
human monocytes | 8 |
fipv rna | 8 |
fret assay | 8 |
subgenomic mrna | 8 |
coronavirus ibv | 8 |
fhr peptide | 8 |
fipv main | 8 |
mild enteritis | 8 |
qpcr assay | 8 |
electron microscopy | 8 |
heptad repeat | 8 |
protect cats | 8 |
deletion mutant | 8 |
structural gene | 8 |
survival rate | 8 |
simple method | 8 |
markedly different | 8 |
tumor cells | 8 |
aldehyde form | 8 |
nk cells | 8 |
fecv genome | 8 |
acid substitutions | 8 |
receptor feline | 8 |
mean plasma | 8 |
capture elisa | 8 |
type fipv | 8 |
many years | 8 |
uninfected cells | 8 |
virus inoculation | 8 |
i strains | 8 |
infected sf | 8 |
group i | 8 |
serologic studies | 8 |
leader sequence | 8 |
fipv peplomer | 8 |
peplomer glycoprotein | 8 |
also observed | 8 |
hela cells | 8 |
cell depletion | 8 |
captive cheetahs | 8 |
cat households | 8 |
sybr green | 8 |
virus adsorption | 8 |
lymph node | 8 |
ii fipvs | 8 |
avirulent feline | 8 |
gene product | 8 |
fip lesions | 8 |
clc bio | 8 |
exposed kittens | 8 |
recombinant feline | 8 |
treatment group | 8 |
replication kinetics | 8 |
pdb id | 8 |
inoculated intraperitoneally | 8 |
fold changes | 8 |
strain df | 8 |
tc epitopes | 8 |
acid residues | 8 |
intestinal tropism | 8 |
high viral | 8 |
gel electrophoresis | 8 |
pcr using | 8 |
herpes simplex | 8 |
pathogenicity based | 8 |
monocyte cell | 8 |
cats developed | 7 |
upregulates expression | 7 |
bred cats | 7 |
increased vascular | 7 |
serotypes i | 7 |
pge levels | 7 |
virus antigen | 7 |
feline fcwf | 7 |
nucleotide identity | 7 |
stop codons | 7 |
study also | 7 |
bispecific antibody | 7 |
parental virus | 7 |
stranded rna | 7 |
control kittens | 7 |
measles virus | 7 |
animal experiments | 7 |
natural type | 7 |
calf diarrhea | 7 |
fcov genome | 7 |
green qpcr | 7 |
pleural effusions | 7 |
infectious virus | 7 |
clpro inhibitor | 7 |
neutralizing mabs | 7 |
closed cat | 7 |
washed times | 7 |
spf cat | 7 |
well plate | 7 |
noneffusive fip | 7 |
seropositive cats | 7 |
free virus | 7 |
cell pellets | 7 |
containing fbs | 7 |
apoptotic gene | 7 |
molecular probes | 7 |
nlfk cells | 7 |
viral disease | 7 |
targeting coronavirus | 7 |
using reverse | 7 |
mrna rt | 7 |
horizontal transmission | 7 |
coronavirus persistence | 7 |
antibody titer | 7 |
possible involvement | 7 |
every days | 7 |
west nile | 7 |
disease course | 7 |
wide range | 7 |
occurring fip | 7 |
serum antibody | 7 |
intracellular transport | 7 |
cells per | 7 |
derived macrophages | 7 |
fc receptors | 7 |
causing fip | 7 |
induce fip | 7 |
antibody titre | 7 |
host factors | 7 |
antigenic cross | 7 |
homologous structural | 7 |
coronavirus clpro | 7 |
target cell | 7 |
feline cell | 7 |
mediated disease | 7 |
studies using | 7 |
fipv spike | 7 |
serum antibodies | 7 |
cats will | 7 |
clinical fip | 7 |
also known | 7 |
virus assembly | 7 |
genetic susceptibility | 7 |
clinical diagnosis | 7 |
early apoptosis | 7 |
first described | 7 |
ascitic fluids | 7 |
type baculovirus | 7 |
acid changes | 7 |
qpcr method | 7 |
fipv arises | 7 |
expression vector | 7 |
porcine coronaviruses | 7 |
cytopathic effects | 7 |
antibody tests | 7 |
inhibit fipv | 7 |
first hpi | 7 |
transcriptase polymerase | 7 |
coronavirus transmissible | 7 |
pleural effusion | 7 |
might also | 7 |
rees feline | 7 |
unclear whether | 7 |
virus suspension | 7 |
animal health | 7 |
coronavirus tgev | 7 |
antibody test | 7 |
showed surface | 7 |
virus growth | 7 |
protein fusion | 7 |
barlough weiss | 7 |
coronavirus feline | 7 |
diverse disease | 7 |
light microscopy | 7 |
serum coronavirus | 7 |
fold dilution | 7 |
innate immune | 7 |
order nidovirales | 7 |
human cells | 7 |
infected pfbm | 7 |
untranslated region | 7 |
weight loss | 7 |
nitrocellulose sheets | 7 |
transcriptional profiling | 7 |
agarose gel | 7 |
either one | 7 |
cell lysate | 7 |
may provide | 7 |
coronavirus nucleocapsid | 7 |
virus isolate | 7 |
coronavirus virulence | 7 |
coronavirus associated | 7 |
dendritic cells | 7 |
heat shock | 7 |
neutralization test | 7 |
antigen positive | 7 |
estimating fifty | 7 |
specific antibody | 7 |
fip incidence | 7 |
purified using | 6 |
different regions | 6 |
protective immunity | 6 |
young cats | 6 |
cats feline | 6 |
mutant viruses | 6 |
peritonitis tnf | 6 |
cats using | 6 |
intestinal epithelial | 6 |
coronavirus pathogenesis | 6 |
like cells | 6 |
cellular immune | 6 |
immune cells | 6 |
affected cats | 6 |
purdue strain | 6 |
plaque reduction | 6 |
primary antibody | 6 |
free supernatants | 6 |
like cell | 6 |
intestinal epithelium | 6 |
i strain | 6 |
mrna pcr | 6 |
ec value | 6 |
tested positive | 6 |
probe energy | 6 |
genus alphacoronavirus | 6 |
competitive binding | 6 |
growth kinetics | 6 |
containing chloroquine | 6 |
gene sequence | 6 |
pedersen boyle | 6 |
attenuated live | 6 |
hr regions | 6 |
inflammatory lesions | 6 |
treated cells | 6 |
expression values | 6 |
none group | 6 |
recombinant virus | 6 |
res doi | 6 |
thermo fisher | 6 |
splenocytes derived | 6 |
regulates pro | 6 |
per sample | 6 |
different groups | 6 |
cats may | 6 |
culture chamber | 6 |
viral suspension | 6 |
fcov pathotypes | 6 |
diarrhea coronavirus | 6 |
coronavirus transcription | 6 |
increased plasma | 6 |
fcov mrna | 6 |
maximum titer | 6 |
virus shedding | 6 |
cat igg | 6 |
cats showed | 6 |
pbml isolated | 6 |
enteric virus | 6 |
lethal systemic | 6 |
type infection | 6 |
virus entry | 6 |
accession number | 6 |
hybridoma cultures | 6 |
compounds targeting | 6 |
triplex formation | 6 |
strongly decreased | 6 |
field viruses | 6 |
wide association | 6 |
neutralizing monoclonal | 6 |
significant differences | 6 |
murine leukemia | 6 |
stimulating factor | 6 |
nile virus | 6 |
dot blot | 6 |
stomatitis virus | 6 |
mutation rate | 6 |
genetic background | 6 |
ge healthcare | 6 |
virus fusion | 6 |
derived feline | 6 |
pathological findings | 6 |
i ucd | 6 |
many cats | 6 |
fcov serotypes | 6 |
terminal part | 6 |
tsutomu title | 6 |
coronavirus fipv | 6 |
various organs | 6 |
coronavirus serotypes | 6 |
molecular weights | 6 |
infected animal | 6 |
virus glycoprotein | 6 |
fifty percent | 6 |
called feline | 6 |
chamber slides | 6 |
cdna probe | 6 |
virus experimental | 6 |
may occur | 6 |
expressed proteins | 6 |
biotype switch | 6 |
human respiratory | 6 |
rna level | 6 |
biological diversity | 6 |
avian infectious | 6 |
escherichia coli | 6 |
specific genes | 6 |
protein may | 6 |
clinical aspects | 6 |
different coronaviruses | 6 |
four cats | 6 |
genome copies | 6 |
cellular processes | 6 |
significantly lower | 6 |
therapeutic drug | 6 |
medium alone | 6 |
peplomer glycoproteins | 6 |
fipv antibodies | 6 |
targeted rna | 6 |
gastroenteritis viruses | 6 |
fcov variants | 6 |
pro apoptotic | 6 |
antibody analysis | 6 |
vivo efficacy | 6 |
two variants | 6 |
studies showed | 6 |
recombination events | 6 |
fip within | 6 |
i fipvs | 6 |
pharmacokinetic data | 6 |
nonpermissive temperature | 6 |
rna isolated | 6 |
physical characteristics | 6 |
cm well | 6 |
kill human | 6 |
cause fip | 6 |
vitro growth | 6 |
expression kinetics | 6 |
neutralizing epitopes | 6 |
forming oligonucleotide | 6 |
abc ab | 6 |
endothelial growth | 6 |
uninfected control | 6 |
plasma pge | 6 |
results showed | 6 |
cell response | 6 |
treat fip | 6 |
passively immunized | 6 |
three major | 6 |
new assay | 6 |
wide significance | 6 |
peritonitis antibody | 6 |
linear tfo | 6 |
also reported | 6 |
pathogenic fipv | 6 |
without surface | 6 |
treated groups | 6 |
least one | 6 |
gastroenteritis coronavirus | 6 |
induced apoptosis | 6 |
imidazole inhibitors | 6 |
plaque size | 6 |
messenger rna | 6 |
well multi | 6 |
animal inoculation | 6 |
melting points | 6 |
buffer containing | 6 |
subsequent studies | 6 |
vesicular stomatitis | 6 |
infect macrophages | 6 |
polyacrylamide gels | 6 |
primary blood | 6 |
viral envelope | 6 |
different epitopes | 6 |
therapeutic effect | 6 |
disease process | 6 |
van der | 6 |
high levels | 6 |
high titers | 6 |
horseradish peroxidase | 6 |
humoral immune | 6 |
human fc | 6 |
mediated immunity | 6 |
cats immunized | 6 |
cats without | 6 |
detect fipv | 6 |
fipv biotype | 6 |
conjugated goat | 6 |
upregulated genes | 6 |
solution containing | 6 |
virulent feline | 6 |
mouse model | 6 |
induced antiviral | 6 |
peptidyl compounds | 6 |
receptor activity | 6 |
infected tissue | 6 |
hybridoma cell | 6 |
recent study | 6 |
transcriptase pcr | 6 |
protease inhibitors | 6 |
antibody technique | 6 |
coronaviruses feline | 6 |
hydrogen bonds | 6 |
recombinant human | 6 |
field isolate | 6 |
cdna clone | 6 |
clinically healthy | 6 |
feline mononuclear | 6 |
among different | 6 |
coronavirus characterization | 6 |
fipv mabs | 6 |
ascites fluid | 6 |
subclinical infections | 6 |
feline bone | 6 |
essential amino | 6 |
bispecific scfv | 6 |
modified live | 6 |
low level | 6 |
pseudorabies virus | 6 |
coronavirus pathobiogenesis | 6 |
cat infection | 6 |
studies conducted | 6 |
either fipv | 6 |
density gradient | 6 |
natural resistance | 6 |
peritonitis cases | 6 |
using fipv | 6 |
macrophage infection | 6 |
detection limit | 6 |
severe clinical | 6 |
cells using | 6 |
cd ligand | 6 |
vaccinia viruses | 6 |
one hand | 6 |
recombinant rna | 6 |
fcov orf | 6 |
nonstructural proteins | 6 |
authors declare | 6 |
accelerated fip | 6 |
syndrome virus | 6 |
genetic factors | 6 |
fcov strain | 6 |
unpublished data | 6 |
multicat environments | 6 |
fisher scientific | 6 |
cats succumbed | 6 |
tgev orf | 6 |
among homologous | 6 |
field isolates | 6 |
specific monoclonal | 6 |
low levels | 6 |
fipv proteins | 6 |
last years | 6 |
protein expression | 6 |
epidemiology based | 6 |
protective immune | 6 |
reveals large | 5 |
antibody titres | 5 |
enteric viral | 5 |
two groups | 5 |
cell immunity | 5 |
expression product | 5 |
young age | 5 |
strains ucd | 5 |
abdul rahman | 5 |
cells expressing | 5 |
performed according | 5 |
military dogs | 5 |
confluent fcwf | 5 |
qpcr test | 5 |
avirulent fipv | 5 |
mutant strain | 5 |
disease occurs | 5 |
fip occurs | 5 |
disease virus | 5 |
tgev purdue | 5 |
mild diarrhea | 5 |
endothelial cells | 5 |
university college | 5 |
pcr primers | 5 |
spanning membrane | 5 |
molecular characterization | 5 |
protection studies | 5 |
show significant | 5 |
free water | 5 |
naturally fcov | 5 |
fip ascitic | 5 |
without passive | 5 |
coronaviral infections | 5 |
specific proteins | 5 |
persistent feline | 5 |
protein alone | 5 |
host response | 5 |
virus detected | 5 |
sequences derived | 5 |
fipv igg | 5 |
virus regulates | 5 |
pge plasma | 5 |
respiratory syncytial | 5 |
transcription factor | 5 |
replicase gene | 5 |
total volume | 5 |
cross reaction | 5 |
ade macrophages | 5 |
fipv nucleocapsid | 5 |
peritonitis two | 5 |
immune signaling | 5 |
th epitope | 5 |
pathogenic characteristics | 5 |
peer review | 5 |
distributed worldwide | 5 |
significant increases | 5 |
analysis revealed | 5 |
macrophages treated | 5 |
human egfr | 5 |
previously published | 5 |
maximum fluorescence | 5 |
except tfo | 5 |
host gene | 5 |
nte buffer | 5 |
two orfs | 5 |
cats dying | 5 |
porcine reproductive | 5 |
susceptible cats | 5 |
nested pcr | 5 |
different peplomer | 5 |
recombinant baculovirus | 5 |
cellular factors | 5 |
subgenomic mrnas | 5 |
free cats | 5 |
macrophages monocytes | 5 |
autochthonous peritoneal | 5 |
vitro infection | 5 |
antigenic group | 5 |
clinically normal | 5 |
way anova | 5 |
clinical outcomes | 5 |
virus expressing | 5 |
arachidonic acid | 5 |
blot analysis | 5 |
tgev strains | 5 |
novel tool | 5 |
bound antibodies | 5 |
circulating virulent | 5 |
sodium pyruvate | 5 |
responses may | 5 |
virus infected | 5 |
feline gapdh | 5 |
cu cell | 5 |
generally accepted | 5 |
related feline | 5 |
virus mediate | 5 |
fipv abc | 5 |
apoptotic genes | 5 |
diarrheal coronavirus | 5 |
times higher | 5 |
inoculated orally | 5 |
permissive temperature | 5 |
igg subclass | 5 |
signaling pathway | 5 |
feline ifn | 5 |
assay using | 5 |
purebred catteries | 5 |
using primers | 5 |
mm sodium | 5 |
neutrophil apoptosis | 5 |
experimental challenge | 5 |
species tropism | 5 |
washed twice | 5 |
retention signal | 5 |
cell epitopes | 5 |
without fipv | 5 |
fusion activation | 5 |
inoculation studies | 5 |
peritonitis attempted | 5 |
antiviral properties | 5 |
polyclonal antibodies | 5 |
earlier study | 5 |
may cause | 5 |
pcr kit | 5 |
containing fcs | 5 |
expressed protein | 5 |
fusion core | 5 |
companion animal | 5 |
induced macrophages | 5 |
also appears | 5 |
viral titers | 5 |
accessory protein | 5 |
neutralizing epitope | 5 |
factors act | 5 |
forming oligonucleotides | 5 |
virus titres | 5 |
binding protein | 5 |
coronavirus exposure | 5 |
natural infection | 5 |
three structural | 5 |
oral inoculation | 5 |
alpha capture | 5 |
gamma interferon | 5 |
postmortem examination | 5 |
specific mabs | 5 |
related group | 5 |
peritoneal cell | 5 |
related coronavirus | 5 |
recognizing different | 5 |
bovine papilloma | 5 |
thaw cycles | 5 |
different cell | 5 |
efficacy study | 5 |
nucleic acids | 5 |
virus dilution | 5 |
stable expression | 5 |
continuous cell | 5 |
within days | 5 |
virus vtf | 5 |
partial base | 5 |
virus grown | 5 |
rna replication | 5 |
monocytes without | 5 |
acid metabolites | 5 |
statistical analysis | 5 |
antibodies enhancement | 5 |
cell membrane | 5 |
virus feline | 5 |
crandell rees | 5 |
following formula | 5 |
genetic basis | 5 |
simian immunodeficiency | 5 |
days post | 5 |
bispecific single | 5 |
five cats | 5 |
viral diseases | 5 |
two thirds | 5 |
tgev reveals | 5 |
pivotal role | 5 |
low ph | 5 |
disequilibrium test | 5 |
winn feline | 5 |
factor receptor | 5 |
moloney murine | 5 |
also determined | 5 |
i probe | 5 |
viral proliferation | 5 |
many organs | 5 |
one hundred | 5 |
fipv clpro | 5 |
primer sequences | 5 |
following experimental | 5 |
antigenic cluster | 5 |
rna binding | 5 |
viral protein | 5 |
rat coronavirus | 5 |
fipv grown | 5 |
produced maximum | 5 |
tfo showed | 5 |
significantly decreased | 5 |
negative control | 5 |
complement system | 5 |
next generation | 5 |
genes involved | 5 |
genetic diversity | 5 |
assay variability | 5 |
three days | 5 |
mapk inhibitors | 5 |
using monoclonal | 5 |
tissue homogenates | 5 |
human tumor | 5 |
orf ab | 5 |
glass works | 5 |
type hypersensitivity | 5 |
serial dilutions | 5 |
coronavirus mrnas | 5 |
standardized plaque | 5 |
critical role | 5 |
peritonitis detection | 5 |
viral presence | 5 |
cell function | 5 |
serologic testing | 5 |
cytokine mrnas | 5 |
among feline | 5 |
fip among | 5 |
fipv negative | 5 |
four peptides | 5 |
calf diarrheal | 5 |
induced tnf | 5 |
infect cats | 5 |
monocytes inoculated | 5 |
experimental infections | 5 |
conjugated rabbit | 5 |
coronavirus oc | 5 |
occur via | 5 |
fipv antigenic | 5 |
culture cells | 5 |
transmission disequilibrium | 5 |
virus genetic | 5 |
purified virus | 5 |
major structural | 5 |
verified feline | 5 |
sense rna | 5 |
related coronaviruses | 5 |
conformational changes | 5 |
safety study | 5 |
cats tested | 5 |
granulomatous inflammation | 5 |
systemic disease | 5 |
viral entry | 5 |
detection system | 5 |
macrophages inoculated | 5 |
acid identity | 5 |
ammonium sulfate | 5 |
balanced salt | 5 |
cdna copy | 5 |
coronavirus field | 5 |
sodium dodecyl | 5 |
stained cells | 5 |
transformed cell | 5 |
body weight | 5 |
vitro antiviral | 5 |
switching species | 5 |
helix forming | 5 |
feline macrophage | 5 |
rna samples | 5 |
antibodies recognizing | 5 |
integral membrane | 5 |
stray cats | 5 |
larger plaques | 5 |
induced ade | 5 |
absolute acetone | 5 |
single nucleotide | 5 |
standard curve | 5 |
terminal signal | 5 |
provide protection | 5 |
coronavirus mouse | 5 |
disease called | 5 |
statistically significant | 5 |
inflammatory diseases | 5 |
independent evaluation | 5 |
enhanced infection | 5 |
lg ml | 5 |
one study | 5 |
protein induces | 5 |
significant reduction | 5 |
ih protein | 5 |
virus titre | 5 |
cells via | 5 |
lung cells | 5 |
acid differences | 5 |
point analysis | 5 |
primers specific | 5 |
antigenic comparison | 5 |
sequence comparison | 5 |
sample buffer | 5 |
asymptomatic infection | 5 |
effective way | 5 |
remains unclear | 5 |
three distinct | 5 |
fcov replication | 5 |
following challenge | 5 |
antiviral drug | 5 |
primary isolation | 5 |
entire orf | 5 |
cell receptor | 5 |
varies among | 5 |
may result | 5 |
normal cats | 5 |
mediated infection | 5 |
homology among | 5 |
systemic spread | 5 |
show surface | 5 |
dmso alone | 5 |
potent inhibition | 5 |
dmem containing | 5 |
virus isolates | 5 |
histopathologically verified | 5 |
much lower | 5 |
spectrum inhibitors | 5 |
biotypes feline | 5 |
genes provide | 5 |
structural genes | 5 |
small deletions | 5 |
genome sequence | 5 |
different virus | 5 |
slightly lower | 5 |
i interferon | 5 |
immunofluorescence assay | 5 |
core complex | 5 |
genetic variation | 5 |
relatively high | 5 |
survival factor | 5 |
determined whether | 5 |
kinase pathways | 5 |
microtiter plates | 5 |
dengue viruses | 5 |
dependent manner | 5 |
selected genes | 5 |
units ml | 5 |
reported previously | 5 |
tissue samples | 5 |
ng ml | 5 |
cell free | 5 |
persistent infection | 5 |
culture media | 5 |
enteric disease | 5 |
cdna preparation | 5 |
animal care | 5 |
black strain | 5 |
mice immunized | 5 |
binding assay | 5 |
two control | 5 |
despite absence | 5 |
cellular composition | 5 |
cats naturally | 5 |
virus immunologic | 5 |
different organs | 5 |
enteritis virus | 5 |
loads despite | 5 |
san diego | 5 |
kittens demonstrated | 5 |
measured using | 5 |
like fipv | 5 |
granulomatous vasculitis | 5 |
viral load | 5 |
expression system | 5 |
genetic changes | 5 |
differential expression | 5 |
present time | 5 |
positive samples | 5 |
functional characterization | 5 |
neighboring cells | 5 |
strains used | 5 |
ltb plasma | 5 |
causes fip | 5 |
immunodominant antibody | 5 |
kegg pathways | 5 |
cats develop | 5 |
feline enteritis | 5 |
cell proliferation | 5 |
syncytial virus | 5 |
genbank accession | 5 |
fip treatment | 5 |
levels occurred | 5 |
length cdna | 5 |
tgev strain | 5 |
equine herpesvirus | 5 |
percent endpoints | 5 |
multidimensional scaling | 5 |
coronavirus types | 5 |
derived mononuclear | 5 |
relatively small | 5 |
alpha produced | 5 |
fluorescence microscope | 5 |
avian coronaviruses | 5 |
fecal samples | 5 |
papilloma virus | 5 |
human cytomegalovirus | 5 |
well culture | 5 |
second group | 5 |
diseases center | 5 |
induce apoptosis | 5 |
cleavage sites | 5 |
prior exposure | 5 |
sequence differences | 5 |
commercially available | 5 |
vast majority | 5 |
fipv causes | 5 |
immune evasion | 5 |
mm nacl | 5 |
inflammatory response | 5 |
directed deletion | 5 |
newborn pigs | 5 |
salt solution | 5 |
several studies | 5 |
cell apoptosis | 4 |
neutrophil counts | 4 |
sodium bicarbonate | 4 |
administered every | 4 |
virus genome | 4 |
feline eoronavirus | 4 |
antigenic analysis | 4 |
high degree | 4 |
associated coronavirus | 4 |
monocytes feline | 4 |
specific mutations | 4 |
associated factor | 4 |
transformed cells | 4 |
pcr fragments | 4 |
acting elements | 4 |
oxoid agar | 4 |
antiviral response | 4 |
genome replication | 4 |
korean cats | 4 |
varying degrees | 4 |
oi kuan | 4 |
replication strategy | 4 |
virus date | 4 |
enterotropic mouse | 4 |
developed clinical | 4 |
reaction containing | 4 |
rpmi medium | 4 |
infection phenotype | 4 |
pp ab | 4 |
virulent avirulent | 4 |
economically important | 4 |
coronaviruses antigenic | 4 |
fipv induced | 4 |
positive result | 4 |
anti apoptotic | 4 |
fecal virus | 4 |
specific rna | 4 |
isg transcript | 4 |
first week | 4 |
table shows | 4 |
base pair | 4 |
nucleoside analog | 4 |
specific antiviral | 4 |
whether fipv | 4 |
mutations may | 4 |
post mortem | 4 |
different cats | 4 |
chain kinase | 4 |
early viral | 4 |
cytoplasmic expression | 4 |
viruses fipv | 4 |
rectal swab | 4 |
associated growth | 4 |
binding pocket | 4 |
virus mutants | 4 |
mock infected | 4 |
several coronaviruses | 4 |
designated fipv | 4 |
subfamily coronavirinae | 4 |
whether scfv | 4 |
high percentage | 4 |
protein band | 4 |
binding ability | 4 |
gross lesions | 4 |
liver enzymes | 4 |
using clc | 4 |
associated protein | 4 |
cats suspected | 4 |
peritonitis date | 4 |
virus contribute | 4 |
may function | 4 |
question remains | 4 |
subgenomic rnas | 4 |
two types | 4 |
rox one | 4 |
leukocyte suspension | 4 |
protein bands | 4 |
strain ku | 4 |
alpha mrna | 4 |
length genome | 4 |
clearly show | 4 |
statistical significance | 4 |
enzyme mix | 4 |
strain used | 4 |
cats living | 4 |
diagnostic test | 4 |
young kittens | 4 |
enhancing activity | 4 |
viral membrane | 4 |
oriented around | 4 |
current study | 4 |
purebred cats | 4 |
peritonitis using | 4 |
candidate genes | 4 |
vivo cytokine | 4 |
coronavirus peplomer | 4 |
culture infective | 4 |
yellow fever | 4 |
genetic variants | 4 |
rneasy mini | 4 |
feline foundation | 4 |
apoptosis process | 4 |
surface projections | 4 |
infectious dose | 4 |
designated orf | 4 |
gel extraction | 4 |
ml scfv | 4 |
cv antigen | 4 |
thank dr | 4 |
replicase transcriptase | 4 |
derived alveolar | 4 |
stranded dna | 4 |
inhibited fipv | 4 |
adhesion molecules | 4 |
cells used | 4 |
cells also | 4 |
pcr methods | 4 |
conserved among | 4 |
samples collected | 4 |
proteins since | 4 |
partial nucleotide | 4 |
early death | 4 |
natural killer | 4 |
genomic deletions | 4 |
using fcwf | 4 |
coronavirus related | 4 |
inoculated kittens | 4 |
virus envelope | 4 |
factor production | 4 |
coronavirus orf | 4 |
cov strains | 4 |
extracellular virus | 4 |
je genome | 4 |
mediate antibody | 4 |
van hamme | 4 |
linear immunodominant | 4 |
genetics approach | 4 |
field conditions | 4 |
deregulated genes | 4 |
will grow | 4 |
mrna positive | 4 |
novel type | 4 |
control cats | 4 |
feline igg | 4 |
surface antigens | 4 |
local immunity | 4 |
gibco brl | 4 |
using standard | 4 |
layered onto | 4 |
without chloroquine | 4 |
virus also | 4 |
abcd guidelines | 4 |
hepes buffer | 4 |
viral pathogens | 4 |
east respiratory | 4 |
coronavirus antigen | 4 |
infection causes | 4 |
strain ucd | 4 |
fused cells | 4 |
hybridization signal | 4 |
gibcobrl life | 4 |
remaining genes | 4 |
collected every | 4 |
containing units | 4 |
also studied | 4 |
evaluated using | 4 |
cl cells | 4 |
tenfold virus | 4 |
whether hcq | 4 |
tge virus | 4 |
fever virus | 4 |
discontinuous transcription | 4 |
flow cytometry | 4 |
employ another | 4 |
harold kaye | 4 |
mediate ade | 4 |
cell protein | 4 |
cell membranes | 4 |
fold reduction | 4 |
fip biotype | 4 |
among coronaviruses | 4 |
adverse effects | 4 |
humoral immunity | 4 |
highest dilution | 4 |
post hoc | 4 |
following incubation | 4 |
mediated immune | 4 |
three different | 4 |
igg mab | 4 |
lr cells | 4 |
cats treated | 4 |
virus pathogenesis | 4 |
coil structure | 4 |
one gene | 4 |
death domain | 4 |
specific pabs | 4 |
avirulent strains | 4 |
ethidium bromide | 4 |
protein expressed | 4 |
control supernatant | 4 |
comparable antiviral | 4 |
fecv infected | 4 |
peritonitis experimental | 4 |
glass coverslips | 4 |
petri dishes | 4 |
showed high | 4 |
virus inoculated | 4 |
least three | 4 |
cats passively | 4 |
complex pathogenesis | 4 |
coronavirus group | 4 |
gradient centrifugation | 4 |
protein derived | 4 |
signal transduction | 4 |
fipv alone | 4 |
feline population | 4 |
also used | 4 |
discriminatory mutations | 4 |
causes feline | 4 |
gene expressions | 4 |
enveloped virus | 4 |
plasmid dna | 4 |
interstructural gene | 4 |
sc resulted | 4 |
positive correlation | 4 |
simian virus | 4 |
fi ndings | 4 |
cat serum | 4 |
transformed cl | 4 |
highly related | 4 |
minimal essential | 4 |
pstl fragment | 4 |
causes mild | 4 |
rad cfx | 4 |
synthetic oligonucleotide | 4 |
coronaviruses date | 4 |
cell interactions | 4 |
luciferase reporter | 4 |
infection time | 4 |
drug design | 4 |
colony stimulating | 4 |
cats originated | 4 |
restored orf | 4 |
identical serotype | 4 |
sensitive feline | 4 |
coronaviruses may | 4 |
intranasal inoculation | 4 |
takara bio | 4 |
poor prognosis | 4 |
regulatory factor | 4 |
pig anti | 4 |
active sites | 4 |
cov infection | 4 |
single base | 4 |
molecular pathogenesis | 4 |
kda protein | 4 |
medium supplemented | 4 |
mm fhr | 4 |
increased replication | 4 |
infections feline | 4 |
viral transcription | 4 |
noneffusive form | 4 |
normal state | 4 |
also thank | 4 |
apparently healthy | 4 |
interfering rnas | 4 |
widely accepted | 4 |
lactate dehydrogenase | 4 |
just upstream | 4 |
mhv strain | 4 |
feline health | 4 |
red triangles | 4 |
various coronaviruses | 4 |
sick cats | 4 |
use committee | 4 |
antibody assay | 4 |
results show | 4 |
significant genetic | 4 |
enhancing antibodies | 4 |
host immune | 4 |
relatively low | 4 |
main proteases | 4 |
aa metabolites | 4 |
fecv ucd | 4 |
nucleic acid | 4 |
serotype virus | 4 |
faeces suspension | 4 |
geographic regions | 4 |
late apoptosis | 4 |
mortality rate | 4 |
vitro cultivation | 4 |
one group | 4 |
second study | 4 |
febrile response | 4 |
ria kit | 4 |
clinical specimens | 4 |
induces cell | 4 |
plasma hcq | 4 |
fapn expression | 4 |
findings may | 4 |
leica microsystems | 4 |
reaction buffer | 4 |
wide variety | 4 |
single amino | 4 |
experiments using | 4 |
und der | 4 |
light chain | 4 |
ed dubovi | 4 |
endothelial cell | 4 |
proteins abc | 4 |
cats characterization | 4 |
commercial drugs | 4 |
authors concluded | 4 |
sublethal dose | 4 |
cancer cell | 4 |
mediated entry | 4 |
viruses within | 4 |
supernatant containing | 4 |
coronavirus accessory | 4 |
barnhi site | 4 |
penicillin ml | 4 |
site downstream | 4 |
molecular cloning | 4 |
globulin ratio | 4 |
results obtained | 4 |
inactivated virus | 4 |
tcids ml | 4 |
pyogranulomatous lesions | 4 |
unrelated cats | 4 |
weeks later | 4 |
fip symptoms | 4 |
feline panleukopenia | 4 |
corona virus | 4 |
multicat households | 4 |
plaque formation | 4 |
coronaviruses fipv | 4 |
binding site | 4 |
reacted strongly | 4 |
high level | 4 |
complement control | 4 |
canine parvovirus | 4 |
antigenically unrelated | 4 |
serological investigations | 4 |
relationship among | 4 |
hiv infection | 4 |
strain black | 4 |
fip may | 4 |
truncating mutations | 4 |
avirulent fcov | 4 |
large amounts | 4 |
fcwf cell | 4 |
virulent fcov | 4 |
yet available | 4 |
fipv neutralizing | 4 |
genome expression | 4 |
mutations occur | 4 |
gel containing | 4 |
cov clpro | 4 |
fatal peritonitis | 4 |
ethanol precipitation | 4 |
fipv vaccines | 4 |
three independent | 4 |
expression vectors | 4 |
possible role | 4 |
receptor density | 4 |
master gene | 4 |
cells produced | 4 |
enveloped viruses | 4 |
molecular mechanisms | 4 |
morphologic features | 4 |
cytokine patterns | 4 |
will replicate | 4 |
functional domains | 4 |
additional orf | 4 |
lipid raft | 4 |
related species | 4 |
subcutaneously administered | 4 |
using crfk | 4 |
supplementary material | 4 |
genetic system | 4 |
binding epitopes | 4 |
cell receptors | 4 |
nuclei per | 4 |
specific interaction | 4 |
viral structural | 4 |
wet fip | 4 |
various forms | 4 |
different cellular | 4 |
human macrophages | 4 |
putative fp | 4 |
also show | 4 |
tested negative | 4 |
qpcr assays | 4 |
electrophoretic transfer | 4 |
medical teaching | 4 |
receptor usage | 4 |
epizootic outbreak | 4 |
sindbis virus | 4 |
site located | 4 |
rnase inhibitor | 4 |
pig serum | 4 |
apoptosis cluster | 4 |
using either | 4 |
acetic acid | 4 |
cellular functions | 4 |
peritonitis pathogenesis | 4 |
target tissues | 4 |
virology doi | 4 |
per gene | 4 |
mouse monoclonal | 4 |
cytokine response | 4 |
data suggest | 4 |
primary infection | 4 |
technical assistance | 4 |
virus bands | 4 |
coronavirus differs | 4 |
fever pathogenesis | 4 |
peritonitis natural | 4 |
interferon regulatory | 4 |
heparinized blood | 4 |
fetus cells | 4 |
species specificity | 4 |
viral genomes | 4 |
different disease | 4 |
hr chase | 4 |
proteins appeared | 4 |
absolute lymphopenia | 4 |
taken together | 4 |
extraperitoneal lesions | 4 |
conserved region | 4 |
orally inoculated | 4 |
coronavirus vaccines | 4 |
also occur | 4 |
transcription complex | 4 |
antiviral agents | 4 |
evidence indicates | 4 |
dodds scott | 4 |
i fecvs | 4 |
cv hyperimmune | 4 |
streptomycin ml | 4 |
sensitive fipv | 4 |
genome copy | 4 |
viral pathogenicity | 4 |
nucleocapsid proteins | 4 |
hcq level | 4 |
blood leukocytes | 4 |
highly lethal | 4 |
inactivation curve | 4 |
helix formation | 4 |
alone showed | 4 |
containing approximately | 4 |
antiviral responses | 4 |
swab samples | 4 |
nested set | 4 |
high titer | 4 |
base sequence | 4 |
fip also | 4 |
experimental fipv | 4 |
monocyte cultures | 4 |
lipid rafts | 4 |
granulomatous disease | 4 |
investigate whether | 4 |
probe hybridized | 4 |
virus interactions | 4 |
mutations responsible | 4 |
fcov positive | 4 |
immunofluorescent studies | 4 |
may allow | 4 |
crfk cell | 4 |
superscript ii | 4 |
cdna clones | 4 |
real time | 4 |
fapn cells | 4 |
buffer consisting | 4 |
cellular proteins | 4 |
luciferase activities | 4 |
avian influenza | 4 |
become infected | 4 |
full genome | 4 |
mrna detection | 4 |
since fipv | 4 |
cellular entry | 4 |
conjugated anti | 4 |
nine reference | 4 |
fecv isolates | 4 |
administered orally | 4 |
increased liver | 4 |
serial ten | 4 |
reaction conditions | 4 |
significantly different | 4 |
buffered formalin | 4 |
method using | 4 |
life cycle | 4 |
turkey coronavirus | 4 |
encephalitis virus | 4 |
neonatal calf | 4 |
acute phase | 4 |
nine structural | 4 |
factor alpha | 4 |
attenuated coronavirus | 4 |
national institutes | 4 |
immunized cats | 4 |
viral mrna | 4 |
middle east | 4 |
isolated using | 4 |
per syncytium | 4 |
undertaken using | 4 |
blot hybridization | 4 |
strains fipv | 4 |
healthy spf | 4 |
anti cv | 4 |
virus spike | 4 |
igg antibody | 4 |
candidate compounds | 4 |
fip remains | 4 |
may indicate | 4 |
cmi responses | 4 |
different clinical | 4 |
bovine enteric | 4 |
extraction kit | 4 |
synthetic peptides | 4 |
cell sheet | 4 |
bovine papillomavirus | 4 |
mouse mabs | 4 |
different tissue | 4 |
myosin light | 4 |
alpha interferon | 4 |
gene enrichment | 4 |
cl protease | 4 |
miller strain | 4 |
inflammatory cells | 4 |
standard error | 4 |
study using | 4 |
mediated internalization | 4 |
well documented | 4 |
initial infection | 4 |
fully restored | 4 |
dengue strains | 4 |
cdna cloning | 4 |
important disorders | 4 |
fcov antibody | 4 |
probably due | 4 |
secreting hybridoma | 4 |
two fcov | 4 |
teaching hospitals | 4 |
bottomed microplates | 4 |
coronavirus evolution | 4 |
i fecv | 4 |
population substructure | 4 |
significant inhibitory | 4 |
tgev clpro | 4 |
recombinant serotype | 4 |
highly variable | 4 |
infecting virus | 4 |
epidermal growth | 4 |
syncytia formation | 4 |
consensus sequence | 4 |
liquid scintillation | 4 |
adherent cells | 4 |
communicable diseases | 4 |
controls showed | 4 |
expression analysis | 4 |
humidified chamber | 4 |
cause clinical | 4 |
negative cat | 4 |
may accompany | 4 |
discordant sib | 4 |
new coronavirus | 4 |
genetics system | 4 |
culture adapted | 4 |
lower part | 4 |
parent strain | 4 |
viral etiology | 4 |
serum components | 4 |
mapk phosphorylation | 4 |
induces vascular | 4 |
future studies | 4 |
developed non | 4 |
fecv infections | 4 |
derived genomic | 4 |
also investigated | 4 |
deleterious mutations | 4 |
virus alone | 4 |
downregulated genes | 4 |
inactivated fipv | 4 |
avirulent fcovs | 4 |
higher titers | 4 |
recombinant cdna | 4 |
trs motif | 4 |
authors thank | 4 |
coronavirus main | 4 |
santa cruz | 4 |
fipv antigens | 4 |
molecular functions | 4 |
permissive feline | 4 |
analog gs | 4 |
qiaamp viral | 4 |
bioinformatic analysis | 4 |
black virus | 4 |
proteolytic processing | 4 |
using specific | 4 |
macrophages overproduce | 4 |
frozen sections | 4 |
cells derived | 4 |
gapdh mrna | 4 |
twice daily | 4 |
related viruses | 4 |
ltb levels | 4 |
pathogenetic mechanisms | 4 |
highly fatal | 4 |
carcinoembryonic antigen | 4 |
altered expression | 4 |
ccv cdna | 3 |
adapted sars | 3 |
transcriptome studies | 3 |
synthesis occurred | 3 |
virtual screening | 3 |
culture adaptation | 3 |
mabs reacted | 3 |
clinical isolates | 3 |
hr post | 3 |
observations suggest | 3 |
ocular involvement | 3 |
fipv rec | 3 |
donor cats | 3 |
highly cell | 3 |
additional file | 3 |
two weeks | 3 |
enrichment analyses | 3 |
also subjected | 3 |
microbiology doi | 3 |
one cycle | 3 |
intestinal villi | 3 |
generally cause | 3 |
study showed | 3 |
streptomycin per | 3 |
enteric pathogens | 3 |
veterinary practitioners | 3 |
cells increased | 3 |
viruses containing | 3 |
fc region | 3 |
virus mutation | 3 |
systemic lupus | 3 |
two dimensions | 3 |
amplification products | 3 |
coronavirus family | 3 |
recombination sites | 3 |
also significantly | 3 |
page analysis | 3 |
method revealed | 3 |
serologic assays | 3 |
different fipv | 3 |
pbs solution | 3 |
protein binding | 3 |
natural populations | 3 |
carboxymethyl cellulose | 3 |
cats prevalence | 3 |
single mutations | 3 |
group coronavirus | 3 |
disseminated fip | 3 |
completely eliminated | 3 |
rna sequences | 3 |
forming units | 3 |
hyperimmune sera | 3 |
including feline | 3 |
two antigenically | 3 |
cytotoxic concentration | 3 |
mediate immune | 3 |
complementmediated lysis | 3 |
proteinimmunized mice | 3 |
black replication | 3 |
circulating antibodies | 3 |
kuan choong | 3 |
rna transcripts | 3 |
sulfate precipitation | 3 |
fcov spike | 3 |
still unclear | 3 |
detect virus | 3 |
fipv transition | 3 |
coronaviral infection | 3 |
clustered together | 3 |
genome regions | 3 |
pcr method | 3 |
significantly differ | 3 |
also demonstrated | 3 |
monoctonal antibodies | 3 |
genetic homogeneity | 3 |
passive immunity | 3 |
competing interests | 3 |
short time | 3 |
caused fip | 3 |
raw sequences | 3 |
band density | 3 |
data collection | 3 |
antiviral signaling | 3 |
mammalian coronaviruses | 3 |
protease broad | 3 |
cheetah coronavirus | 3 |
tropism switching | 3 |
big dye | 3 |
positive titre | 3 |
cells date | 3 |
first genomic | 3 |
genetic component | 3 |
neutralized fecv | 3 |
ct method | 3 |
protein sequence | 3 |
survival times | 3 |
centrifuged twice | 3 |
nucleotide mutations | 3 |
seropositive kittens | 3 |
mrna synthesis | 3 |
canine eoronavirus | 3 |
may become | 3 |
peritonitis morphologic | 3 |
tissue damage | 3 |
coronavirus triple | 3 |
genetic homology | 3 |
unrelated circular | 3 |
feline whole | 3 |
closely clustered | 3 |
situ hybridization | 3 |
diagnostic value | 3 |
roche diagnostics | 3 |
macrophagelike cell | 3 |
cats persistence | 3 |
two new | 3 |
lethal infection | 3 |
single intravenous | 3 |
containing mm | 3 |
cell lymphopenia | 3 |
maximum titers | 3 |
pathological consequences | 3 |
small plaque | 3 |
histopathologically confirmed | 3 |
immune serum | 3 |
antiviral fluorescence | 3 |
spin column | 3 |
closed household | 3 |
largely non | 3 |
peritoneal cells | 3 |
total reads | 3 |
clinical strain | 3 |
polymorphonuclear leukocytes | 3 |
significant production | 3 |
mab cd | 3 |
agarose gels | 3 |
fcov type | 3 |
die antigenverwandtschaft | 3 |
three feline | 3 |
replicate efficiently | 3 |
conventional rt | 3 |
sucrose density | 3 |
hybridization assay | 3 |
higher levels | 3 |
co incubator | 3 |
culture system | 3 |
data indicate | 3 |
peritoneal exudate | 3 |
various gwas | 3 |
negative results | 3 |
fmhv infection | 3 |
sequenced using | 3 |
increased susceptibility | 3 |
mm dtt | 3 |
fcov cdna | 3 |
beckman sw | 3 |
shock promotor | 3 |
extracted rna | 3 |
murine macrophages | 3 |
new jersey | 3 |
similar results | 3 |
antiviral compounds | 3 |
elevated serum | 3 |
enhance infectivity | 3 |
higher viral | 3 |
institutional animal | 3 |
optimal temperature | 3 |
like particle | 3 |
amplified using | 3 |
step rt | 3 |
prolonged time | 3 |
fipv samples | 3 |
bio genomic | 3 |
immunofluorescence using | 3 |
elisa od | 3 |
complement evasion | 3 |
apoptotic cells | 3 |
far less | 3 |
native cv | 3 |
dependent resistance | 3 |
minute wash | 3 |
taq dna | 3 |
guinea pig | 3 |
enhancing ab | 3 |
genome organisation | 3 |
large scale | 3 |
bp fragment | 3 |
study recognizes | 3 |
potentially resulting | 3 |
increased significantly | 3 |
immunosuppressive drugs | 3 |
cat genome | 3 |
observed daily | 3 |
cats examined | 3 |
predicted amino | 3 |
reference strains | 3 |
taiwanese shelter | 3 |
phosphate buffered | 3 |
dry fip | 3 |
younger cats | 3 |
incubated overnight | 3 |
animal species | 3 |
nws virus | 3 |
fipv produced | 3 |
differentially upregulated | 3 |
beta production | 3 |
disease may | 3 |
per kb | 3 |
terminal half | 3 |
enumerable plaques | 3 |
foreign gene | 3 |
rpmi growth | 3 |
infection efficiency | 3 |
dependent enhancing | 3 |
antibody antibody | 3 |
black circles | 3 |
western blots | 3 |
gm ml | 3 |
functional group | 3 |
targeted fipv | 3 |
whole genome | 3 |
mediated cleavage | 3 |
independent studies | 3 |
coronavirus mhv | 3 |
serum proteins | 3 |
gene subgenomic | 3 |
exact mutation | 3 |
increased rapidly | 3 |
elisa kit | 3 |
ribavirin alone | 3 |
feline complement | 3 |
associated death | 3 |
three orfs | 3 |
three genes | 3 |
nucleotide substitutions | 3 |
texas red | 3 |
cv antibodies | 3 |
partial amino | 3 |
enteric biotype | 3 |
clinical forms | 3 |
disease form | 3 |
transcription process | 3 |
virus used | 3 |
become susceptible | 3 |
inducing virus | 3 |
shanghai synchrotron | 3 |
differentially downregulated | 3 |
also explain | 3 |
higher education | 3 |
predicted primary | 3 |
antigenically distinct | 3 |
scottish fold | 3 |
several organs | 3 |
less common | 3 |
experiment using | 3 |
fluorescein isothiocyanate | 3 |
type viruses | 3 |
spread throughout | 3 |
atpase phospholipid | 3 |
laboratoryinduced cases | 3 |
host genes | 3 |
genomic workbench | 3 |
mapk mab | 3 |
infection biology | 3 |
sequences used | 3 |
bart haagmans | 3 |
group vi | 3 |
virus uptake | 3 |
specifically decreased | 3 |
cdna insert | 3 |
agar gel | 3 |
serological investigation | 3 |
supplementary table | 3 |
group iv | 3 |
cats also | 3 |
min incubation | 3 |
fapn receptor | 3 |
receptor aminopeptidase | 3 |
mammalian cell | 3 |
electrophoresis using | 3 |
adcml assays | 3 |
map kinases | 3 |
infections peritonitis | 3 |
resonance energy | 3 |
maturation protein | 3 |
altered receptor | 3 |
antiviral study | 3 |
background display | 3 |
western blotting | 3 |
receptor recognition | 3 |
min per | 3 |
single mutation | 3 |
glycosylation site | 3 |
target viruses | 3 |
coronaviruses correlates | 3 |
large plaques | 3 |
study aimed | 3 |
published reports | 3 |
fipv wellcome | 3 |
infectious rna | 3 |